Literature DB >> 24561611

Antimicrobial prophylaxis in minor and major surgery.

M Bassetti1, E Righi, A Astilean, S Corcione, A Petrolo, E C Farina, F G De Rosa.   

Abstract

Surgical site infections (SSIs) are a frequent cause of morbidity following surgical procedures. Gram-positive cocci, particularly staphylococci, cause many of these infections, although Gram-negative organisms are also frequently involved. The risk of developing a SSI is associated with a number of factors, including aspects of the operative procedure itself, such as wound classification, and patient-related variables, such as preexisting medical conditions. Antimicrobial prophylaxis (AP) plays an important role in reducing SSIs, especially if patient-related risk factors for SSIs are present. The main components of antimicrobial prophylaxis are: timing, selection of drugs and patients, duration and costs. Compliance with these generally accepted preventive principles may lead to overall decreases in the incidence of these infections. Ideally the administration of the prophylactic agent should start within 30 minutes from the surgical incision. The duration of the AP should not exceed 24 hours for the majority of surgical procedures. The shortest effective period of prophylactic antimicrobial administration is not known and studies have demonstrated that post-surgical antibiotic administration is unnecessary. Furthermore, there were no proven benefits in multiple dose regimens when compared to single-dose regimens. The choice of an appropriate prophylactic antimicrobial agent should be based primarily on efficacy and safety. Broad spectrum antibiotics should be avoided due to the risk of promoting bacterial resistance. Cephalosporins are the most commonly used antibiotics in surgical prophylaxis; specifically, cefazolin or cefuroxime are mainly used in the prophylaxis regimens for cardio-thoracic surgery, vascular surgery, hip or knee arthroplasty surgery, neurosurgical procedures and gynecologic and obstetric procedures. A review of the prophylactic regimens regarding the main surgical procedures is presented.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24561611

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  3 in total

1.  Surgical antimicrobial prophylaxis in intensive care unit (ICU) patients: a preliminary, observational, retrospective study.

Authors:  Gary Duclos; Bruno Pastene; Fanny Depeyre; Zoé Meresse; Nadim Cassir; Ignacio Martin-Loeches; Sharon Einav; Laurent Zieleskiewicz; Marc Leone
Journal:  Ann Transl Med       Date:  2018-10

2.  Pre-operative Colonization by Staphylococcus aureus and Cephalosporin Non-susceptible Bacteria in Patients with Proximal Femoral Fractures.

Authors:  Leonardo R Bastos; Mila M Almeida; Elizabeth A Marques; Robson Souza Leão
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2022-01-05

3.  Rationale and study design for an individualised perioperative open-lung ventilatory strategy with a high versus conventional inspiratory oxygen fraction (iPROVE-O2) and its effects on surgical site infection: study protocol for a randomised controlled trial.

Authors:  Carlos Ferrando; Marina Soro; Carmen Unzueta; Jaume Canet; Gerardo Tusman; Fernando Suarez-Sipmann; Julian Librero; Salvador Peiró; Natividad Pozo; Carlos Delgado; Maite Ibáñez; César Aldecoa; Ignacio Garutti; David Pestaña; Aurelio Rodríguez; Santiago García Del Valle; Oscar Diaz-Cambronero; Jaume Balust; Francisco Javier Redondo; Manuel De La Matta; Lucía Gallego; Manuel Granell; Pascual Martínez; Ana Pérez; Sonsoles Leal; Kike Alday; Pablo García; Pablo Monedero; Rafael Gonzalez; Guido Mazzinari; Gerardo Aguilar; Jesús Villar; Francisco Javier Belda
Journal:  BMJ Open       Date:  2017-07-31       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.